BullFrog AI Reports Progress in Drug Discovery for Major Depressive Disorder

BullFrog AI Holdings, Inc. has achieved key commercial project milestones in its drug discovery program for Major Depressive Disorder, utilizing its AI and machine learning platform to identify and prioritize therapeutic targets.